NCX 1000

Drug Profile

NCX 1000

Alternative Names: NCX-1000; NO-ursodeoxycholic acid; NO-ursodiol

Latest Information Update: 15 May 2007

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator NicOx
  • Class Cholic acids; Nitrates
  • Mechanism of Action Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Portal hypertension

Most Recent Events

  • 15 May 2007 Discontinued - Phase-I for Portal hypertension in USA (PO)
  • 15 May 2007 Discontinued - Phase-II for Portal hypertension in Europe (PO)
  • 30 Apr 2007 NCX 1000 is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top